Position in RYTM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$907,559
+$70,212 QoQ
Shares Held
8,174
-15.1% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#163
of 299 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. RYTM ranks #186 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in RYTM
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $907,559 | 8,174 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $837,347 | 9,628 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $17,353,515 | 171,834 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $23,774,731 | 376,242 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $28,344,405 | 535,103 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $38,783,110 | 692,803 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $21,302,559 | 406,615 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $4,385,577 | 106,809 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $855,767 | 19,750 | Shares | Other | 2024-05-15 | |
| 2023-09-30 | $790,774 | 34,494 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $599,757 | 36,371 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $1,674,212 | 93,846 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $619,760 | 21,283 | Shares | Other | 2023-02-14 | |
| 2021-03-31 | $3,802,160 | 178,757 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $569,567 | 19,158 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $610,920 | 28,192 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $228,731 | 10,257 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||